Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer's disease.

MLA

Snider, B.Joy, and David M. Holtzman. “Effects of COVID-19 on Preclinical and Clinical Research in Neurology: Examples from Research on Neurodegeneration and Alzheimer’s Disease.” Neuron, vol. 109, no. 20, Oct. 2021, pp. 3199–202. EBSCOhost, https://doi.org/10.1016/j.neuron.2021.08.026.

APA

Snider, B. J., & Holtzman, D. M. (2021). Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer’s disease. Neuron, 109(20), 3199–3202. https://doi.org/10.1016/j.neuron.2021.08.026

Chicago

Snider, B Joy, and David M Holtzman. 2021. “Effects of COVID-19 on Preclinical and Clinical Research in Neurology: Examples from Research on Neurodegeneration and Alzheimer’s Disease.” Neuron 109 (20): 3199–3202. doi:10.1016/j.neuron.2021.08.026.